Ruz-Caracuel, Ignacio
Rosell, Alejandra
Geryková, Lucie
Gama, João Martins
Alonso-Gordoa, Teresa
Rodríguez-Villena, Amanda
Almeida, Rui
Rosas, Marta
Martínez-Hernández, Rebeca
Martins, Maria João
Ryska, Ales
Eloy, Catarina
Palacios, José
Funding for this research was provided by:
Instituto Ramon y Cajal de Investigación Sanitaria (2021/0453)
Article History
Received: 10 October 2025
Accepted: 26 November 2025
First Online: 5 December 2025
Declarations
:
: Ignacio Ruz-Caracuel has received lecture fees and travel reimbursement from Lilly. Teresa Alonso-Gordoa has received research funding, honoraria, and nonfinancial support from IPSEN, Adacap, Pfizer, Sanofi, EISAI, Lilly, Bayer, Janssen, BMS, Astellas, Novartis, Roche, and MSD. Catarina Eloy has consulted in the last two years for Diapath, Sakura, Biocartis, Paige AI, and Epredia. Catarina Eloy serves as a member of the Editorial Board of Endocrine Pathology. All other authors declare that they have no conflicts of interest related to this work.